Skip to content

Arthroscopically Assisted Versus Open Surgical Reduction of the Hip in Patients With Irreducible DDH Before the Walking Age

Arthroscopically Assisted Versus Open Surgical Reduction of the Hip in Patients With Irreducible DDH Before the Walking Age

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06408987
Enrollment
32
Registered
2024-05-10
Start date
2024-05-15
Completion date
2025-12-15
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Dysplasia of the Hip

Brief summary

To determine the role of arthroscopy in treatment of the DDH.

Detailed description

* The term developmental dysplasia of the hip (DDH) is composed of a spectrum of pathologies from stable acetabular dysplasia (femoral head centered in acetabulum but acetabulum is shallow) to concentric hips that are unstable (femoral head can be moved in and out of the confines of the acetabulum) and frankly dislocated hips in which there is a complete loss of contact between the femoral head and acetabulum. * Open reduction , traditionally through a Smith - Peterson approach should be considered only if closed reduction cannot be performed. * Medial open surgical reduction is a choice for the management of patients younger than 18 months with DDH. The minimal incision and minimal blood loss are advantages of this approach. Limited exposure of the hip joint is a disadvantage. * The arthroscopic procedure was reported to represent a meaningful alternative to the open procedure due to a lower complication rate, a safe setting, a lower rate of residual dysplasia, no observed redislocation and low rate occurrence of osteonecrosis. * All the intra-articular structures (hypertrophic ligamentum teres, transverse acetabular ligament, and pulvinar tissue) in the acetabulum that impede the reduction of the femoral head could be eliminated by using the arthroscopic technique.

Interventions

PROCEDUREarthroscopically assisted

Arthroscopically-Assisted reduction through anterolateral portal for visualization and other accessory portals for instrumentation to achieve reduction and postoperative immobilization in a hip spica.

Open reduction through a bikini incision anterior approach and postoperative immobilization in a hip spica.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Months to 18 Months
Healthy volunteers
Yes

Inclusion criteria

* Inclusion Criteria: * Age: - from nine months to 18 months. * Irreducible Hip Dislocation. *

Exclusion criteria

* Patient age: below 9 months or above 18 months. * Teratologic hip dislocation

Design outcomes

Primary

MeasureTime frameDescription
Determination the success of reduction and incidence of redislocation rateimmediately postoperativeDocumentation of concentric reduction of the hip in immediate postoperative MRI as an assessment tool for the success of the procedure.

Secondary

MeasureTime frameDescription
Assessment of the cosmetic appearance .3 month follow upDocumentation the wound size after 3 months follow up in clinical examination as an assessment tool of cosmotic appearance
Assessment of the shortening1 year follow upAssessment the incidence of leg length discrepancy and shortening that affect walking after one year follow up in clinical examination and x-ray as an assessment tool of shortening
Assessment the incidence stiffness and decrease range of motion of the affected hip1 year follow updocumentation the range of motion of the affected hip and incidence of stiffness after 6 months follow up in clinical examination as an assessment tool of stiffness.
Assessment the incidence of avascular necrosis in the affected hip1 year follow updocumentation the incidence of avascular necrosis of the affected head of hip after one year follow up in clinical examination and x-ray

Contacts

Primary Contactmohamed ebrahim, resident
Mohamed.15259277@med.aun.edu.eg01050707974
Backup Contactmohamed Abd El- Radi, dr
mradi@aun.edu.eg01225338766

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026